ST
UTHR icon

Sageworth Trust’s United Therapeutics UTHR Stock Holding History

Sageworth Trust’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-46
Closed -$10K – 761
2021
Q4 		$10K Sell
46
-154
-77% -$30.2K ﹤0.01% 281
2021
Q3 		$37K Hold
200
– – ﹤0.01% 241
2021
Q2 		$36K Buy
+200
New +$38.1K ﹤0.01% 289

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Sageworth Trust's UTHR Position: Q1 2022 in Review

Sageworth Trust sold out of United Therapeutics (UTHR) in Q1 2022, closing a stake of 46 shares — an estimated $10K sold.

Sageworth Trust first reported a position in UTHR in Q2 2021 and held it in 3 quarters. The position peaked at $37K in Q3 2021. 427 funds tracked by Wall St. Rank hold UTHR as of Q1 2022.

  • Sageworth Trust reported no remaining United Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Sageworth Trust sold 46 United Therapeutics shares in Q1 2022, an estimated $10K.
  • Sageworth Trust first reported a position in United Therapeutics in Q2 2021 and held it in 3 quarters.
  • Sageworth Trust's United Therapeutics position peaked at $37K in Q3 2021.
  • 427 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2022.

Based on Sageworth Trust's 13F filing for Q1 2022, filed 6 May 2022.